MADISON ZEIKLE: Open Payments
NPI 1386393320 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 22 payments from 9 companies in 2025. Trend: 2023 $294 · 2024 $605 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $152 |
| ABBVIE INC. | 5 | $129 |
| Eisai Inc. | 3 | $68 |
| Genmab U.S., Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Verastem, Inc. | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Teleflex LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
Products named: KEYTRUDA, ELAHERE, LYNPARZA, Lenvima, Tivdak, AVMAPKI FAKZYNJA CO-PACK, EPKINLY, JEMPERLI.
Industry payments across MO — which companies pay providers there.
